Celltrion Reportedly Partnering with George Steuart Health on Sri Lankan Remsima (infliximab)

Published date10 April 2017
Law FirmGoodwin
Subject MatterJoint Venture,Biosimilars,Pharmaceutical Industry,Celltrion

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT